Eleftheria Siarava1, Thomas Hyphantis2, Aristeidis H Katsanos3, Sygkliti-Henrietta Pelidou4, Athanassios P Kyritsis5, Sofia Markoula6. 1. Department of Neurology, University of Ioannina, University Hospital of Ioannina, Ioannina, 45110, Greece. Electronic address: esiarav@cc.uoi.gr. 2. Department of Psychiatry, University of Ioannina, University Hospital of Ioannina, Ioannina, 45110, Greece. Electronic address: thomashyphantis@outlook.com. 3. Department of Neurology, University of Ioannina, University Hospital of Ioannina, Ioannina, 45110, Greece. Electronic address: arkatsanos@cc.uoi.gr. 4. Department of Neurology, University of Ioannina, University Hospital of Ioannina, Ioannina, 45110, Greece. Electronic address: epelidou@cc.uoi.gr. 5. Department of Neurology, University of Ioannina, University Hospital of Ioannina, Ioannina, 45110, Greece. Electronic address: thkyrits@uoi.gr. 6. Department of Neurology, University of Ioannina, University Hospital of Ioannina, Ioannina, 45110, Greece. Electronic address: smarkoula@grads.uoi.gr.
Abstract
PURPOSE: The purpose of the present study was to compare depression and QoL between patients with epilepsy and healthy controls, evaluating potentially related factors to depression and QoL in patients with epilepsy in Northwest Greece. METHODS: A case study was conducted in adult patients with epilepsy followed up at the University Hospital of Ioannina and in healthy controls. The Patient Health Questionnaire (PHQ-9) for depression's severity evaluation, the WHOQOL-BREF questionnaire for the QoL estimation and the Adverse Event Profile (AEP) questionnaire for the Antiepileptic Drugs (AEDs) adverse effects assessment were used. RESULTS: Seventy patients with epilepsy and 70 controls were recruited. The PHQ-9 score was higher in patients compared to controls and slightly higher than reported in patients with epilepsy. PHQ-9 was significantly associated with the AEP score. Our patients had a poorer QoL compared to controls. The level of education, the AEP and the PHQ-9 scores were associated to QoL, the last two being the most powerful predictors of QoL. CONCLUSION: Patients with epilepsy in Northwest Greece had higher rates of depression than reported in patients with epilepsy and poorer QoL compared to controls. The adverse effects of AEDs were related to depression in our study, while the adverse effects of AEDs and depression were more powerful predictors of QoL compared to demographics and other characteristics of epilepsy.
PURPOSE: The purpose of the present study was to compare depression and QoL between patients with epilepsy and healthy controls, evaluating potentially related factors to depression and QoL in patients with epilepsy in Northwest Greece. METHODS: A case study was conducted in adult patients with epilepsy followed up at the University Hospital of Ioannina and in healthy controls. The Patient Health Questionnaire (PHQ-9) for depression's severity evaluation, the WHOQOL-BREF questionnaire for the QoL estimation and the Adverse Event Profile (AEP) questionnaire for the Antiepileptic Drugs (AEDs) adverse effects assessment were used. RESULTS: Seventy patients with epilepsy and 70 controls were recruited. The PHQ-9 score was higher in patients compared to controls and slightly higher than reported in patients with epilepsy. PHQ-9 was significantly associated with the AEP score. Our patients had a poorer QoL compared to controls. The level of education, the AEP and the PHQ-9 scores were associated to QoL, the last two being the most powerful predictors of QoL. CONCLUSION:Patients with epilepsy in Northwest Greece had higher rates of depression than reported in patients with epilepsy and poorer QoL compared to controls. The adverse effects of AEDs were related to depression in our study, while the adverse effects of AEDs and depression were more powerful predictors of QoL compared to demographics and other characteristics of epilepsy.
Authors: Alicia Gonzalez-Martinez; Álvaro Planchuelo-Gómez; Alba Vieira Campos; Francisco Martínez-Dubarbie; José Vivancos; María De Toledo-Heras Journal: Neurol Sci Date: 2021-09-15 Impact factor: 3.830
Authors: Rigas G Kalaitzidis; Panagiotis Theofilis; Kalliopi Touchantzidou; Aikaterini Vordoni; Kostas C Siamopoulos; Petros Skapinakis Journal: Int J Environ Res Public Health Date: 2022-02-08 Impact factor: 3.390
Authors: Adnan A Mubaraki; Afnan K Sibyani; Rehab A Alkhawtani; Bashaier G Alqahtani; Faris K Abu Alaynayn Journal: Neurosciences (Riyadh) Date: 2021-10 Impact factor: 0.735